| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 17 |
| 1 | CISPLATIN | 14 |
| 2 | ENFORTUMAB VEDOTIN | 14 |
| 3 | GEMCITABINE HYDROCHLORIDE | 13 |
| 4 | GEMCITABINE | 11 |
| 5 | CARBOPLATIN | 7 |
| 6 | NIVOLUMAB | 6 |
| 7 | PACLITAXEL | 6 |
| 8 | PACLITAXEL (AIBUMIN-BOUND) | 6 |
| 9 | LENALIDOMIDE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NADOFARAGENE FIRADENOVEC-VNCG | 1 | 0.0019 |
| 1 | ENFORTUMAB VEDOTIN | 14 | 0.0018 |
| 2 | BACILLUS CALMETTE-GUERIN | 3 | 0.0017 |
| 3 | MITOMYCIN | 2 | 0.0005 |
| 4 | LUSPATERCEPT | 1 | 0.0004 |
| 5 | HYDROCORTISONE SODIUM SUCCINATE | 1 | 0.0003 |
| 6 | GEMCITABINE HYDROCHLORIDE | 13 | 0.0002 |
| 7 | CISPLATIN | 14 | 0.0002 |
| 8 | PEMBROLIZUMAB | 17 | 0.0002 |
| 9 | DUTASTERIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 3 | 0.0017 |
| 1 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 23 | 0.0002 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 4 | Platinum-based Drug [EPC] | 15 | 0.0001 |
| 5 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 6 | Microtubule Inhibitor [EPC] | 6 | 0.0000 |
| 7 | Interleukin-12 Antagonist [EPC] | 3 | 0.0000 |
| 8 | Interleukin-23 Antagonist [EPC] | 3 | 0.0000 |
| 9 | Leukocyte Growth Factor [EPC] | 3 | 0.0000 |